1. Home
  2. REPL vs HUYA Comparison

REPL vs HUYA Comparison

Compare REPL & HUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REPL
  • HUYA
  • Stock Information
  • Founded
  • REPL 2015
  • HUYA 2014
  • Country
  • REPL United States
  • HUYA China
  • Employees
  • REPL 331
  • HUYA N/A
  • Industry
  • REPL Biotechnology: Pharmaceutical Preparations
  • HUYA Computer Software: Programming Data Processing
  • Sector
  • REPL Health Care
  • HUYA Technology
  • Exchange
  • REPL Nasdaq
  • HUYA Nasdaq
  • Market Cap
  • REPL 1.1B
  • HUYA 831.1M
  • IPO Year
  • REPL 2018
  • HUYA 2018
  • Fundamental
  • Price
  • REPL $13.98
  • HUYA $3.95
  • Analyst Decision
  • REPL Strong Buy
  • HUYA Buy
  • Analyst Count
  • REPL 6
  • HUYA 4
  • Target Price
  • REPL $19.83
  • HUYA $5.68
  • AVG Volume (30 Days)
  • REPL 610.9K
  • HUYA 1.2M
  • Earning Date
  • REPL 02-12-2025
  • HUYA 03-18-2025
  • Dividend Yield
  • REPL N/A
  • HUYA 44.05%
  • EPS Growth
  • REPL N/A
  • HUYA N/A
  • EPS
  • REPL N/A
  • HUYA N/A
  • Revenue
  • REPL N/A
  • HUYA $871,494,902.00
  • Revenue This Year
  • REPL N/A
  • HUYA N/A
  • Revenue Next Year
  • REPL $1,065.54
  • HUYA $7.38
  • P/E Ratio
  • REPL N/A
  • HUYA N/A
  • Revenue Growth
  • REPL N/A
  • HUYA N/A
  • 52 Week Low
  • REPL $4.92
  • HUYA $2.82
  • 52 Week High
  • REPL $17.00
  • HUYA $6.84
  • Technical
  • Relative Strength Index (RSI)
  • REPL 55.54
  • HUYA 63.70
  • Support Level
  • REPL $13.40
  • HUYA $3.82
  • Resistance Level
  • REPL $14.59
  • HUYA $4.11
  • Average True Range (ATR)
  • REPL 0.84
  • HUYA 0.18
  • MACD
  • REPL -0.02
  • HUYA 0.01
  • Stochastic Oscillator
  • REPL 66.52
  • HUYA 77.08

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.

About HUYA HUYA Inc. American depositary shares each representing one ordinary share

Established in 2011, Huya is the largest online game livestreaming company in China. Headquartered in Guangzhou, Huya mainly provides livestreamed videos on esports games such as League of Legends and Honor of Kings and collects virtual tips from viewers. Its products include the Huya Live platform in China and Nimo TV in Southeast Asia and South America. As of 2023, Huya was a subsidiary of Tencent, which owned 63% of its equity stake and held 94% of the voting power.

Share on Social Networks: